Cargando…
Early Outcomes of Bivalirudin Therapy for Thrombotic Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S Vaccination
Vaccine-induced thrombotic thrombocytopenia is a newly described disease process in the setting of expanding access to COVID-19 vaccination. The United States Centers for Disease Control and Prevention recommends treatment with an alternative to heparin in patients suspected of having vaccine-induce...
Autores principales: | Clark, Richard Todd, Johnson, Lee, Billotti, Jamie, Foulds, Georgia, Ketels, Taryn, Heard, Kennon, Calvello Hynes, Emilie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American College of Emergency Physicians.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253724/ https://www.ncbi.nlm.nih.gov/pubmed/34226070 http://dx.doi.org/10.1016/j.annemergmed.2021.04.035 |
Ejemplares similares
-
Ad26.COV2-S: Thrombotic thrombocytopenia and cerebral venous sinus thrombosis: case report
Publicado: (2021) -
Ad26.COV2.S Vaccine-Induced Thrombocytopenia Leading to Dural Sinus Thrombosis and Intracranial Hemorrhage Requiring Hemicraniectomy: A Case Report and Systematic Review
por: Daly, Samuel R, et al.
Publicado: (2022) -
Ad26.cov2-s/AZD-1222: Cerebral venous sinus thrombosis and thrombotic thrombocytopenia: 3 case reports
Publicado: (2022) -
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
por: Muir, Kate-Lynn, et al.
Publicado: (2021) -
Ad26.COV2-S: Thrombotic thrombocytopenia: case report
Publicado: (2021)